Idrx logo

Idrx Funding & Investors

Plymouth, MA

IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision combination therapies. IDRx is headquartered in Plymouth, Massachusetts and was founded in 2022.

idrx.com

Total Amount Raised: $242,550,000

Idrx's Investors

Idrx Funding Rounds

  • Seed

    $250,000

    Seed Investors

    Lisk EMpower Fund

  • Pre Seed

    $300,000

    Pre Seed Investors

    eMerge

  • Series B

    $120,000,000

    Series B Investors

    Blackstone
    Commodore Capital
    RA Capital Management
    Forge Life Science Partners
    Nick Lydon
    Casdin Capital
    Andreessen Horowitz
    Nextech Invest
    Merck KGaA Darmstadt Germany

  • Series A

    $122,000,000

    Series A Investors

    Andreessen Horowitz
    Casdin Capital
    Nextech Invest
    Forge Life Science Partners
Funding info provided by Diffbot.